aTyr Pharma | LIFE - هزینه های فروش





هزینه های فروش تغییر دادن تاریخ
Ardelyx USD 10.85M 6.87M 2025-12
aTyr Pharma USD 3.34M 18.79M 2025-12
Biogen USD 810.1M 205.1M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Cipla INR 29.1B 1.16B 2025-12
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 3.54M 1.89M 2025-12
CSL USD 3.87B 2.08B 2025-12
Curis USD 10.27M 610K 2024-06
Galapagos EUR 455K 84.28M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Grifols EUR 1.51B 184.45M 2025-12
Novartis USD 3.54B 3M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Xoma 116K 112.7K 2024-06